Ingredient or product comparison
GHK-Cu for Rosacea: Product vs Protocol Comparison
Topical serum (1% GHK-Cu, pH 5.2) 1% GHK-Cu + 4% niacinamide Erythema reduction visible weeks 6–8; peak effect weeks 12–16 Twice daily indefinitely; no tachyphylaxis documented Gold standard for barrier repair and long-term vascular stabilization. No tolerance
This source-based comparison does not add ratings or recommend a winner.
- Topical serum (1% GHK-Cu, pH 5.2)
- 1% GHK-Cu + 4% niacinamide
- Erythema reduction visible weeks 6–8; peak effect weeks 12–16
- Twice daily indefinitely; no tachyphylaxis documented
- Gold standard for barrier repair and long-term vascular stabilization. No tolerance or rebound documented
- Compounded cream (0.5% GHK-Cu)
- 0.5% GHK-Cu in ceramide base
- Slower onset; barrier effects visible weeks 8–10
- Once nightly; pair with morning antioxidant serum
- Lower concentration extends shelf life but delays clinical onset; best for sensitive or compromised skin
- Liposomal GHK-Cu (2%)
- 2% encapsulated GHK-Cu
- Penetration enhanced; erythema reduction weeks 4–6
- Twice daily; refrigerate after opening
- Higher bioavailability but formulation instability is common; verify third-party potency testing
- Microneedling + GHK-Cu (1%)
- 1% applied post-procedure
- Single treatment enhances 3-month outcomes by 28% vs topical alone
- Monthly microneedling; daily topical between sessions
- Most aggressive approach for papulopustular rosacea with scarring; requires practitioner oversight
- Oral copper peptide supplementation
- 1–3mg elemental copper daily
- No direct dermal delivery; systemic anti-inflammatory effects only
- Daily indefinitely
- Insufficient evidence for rosacea-specific outcomes; copper supplementation without deficiency risks pro-oxidant effects